Skip to main content
Caplight Logo









Hankang Capital

Hankang Capital

Shanghaichinahic.com

Overview

Hankang Capital is a venture capital firm based in Shanghai, China, that focuses on investments in the healthcare, biotechnology, and pharmaceutical sectors.

Year Founded

2010

Portfolio Companies

1

Investments

Hankang Capital investments
CompanyDateStageLead
Xiamen LP Pharmaceutical Co., Ltd.Aug 2015Series ALead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Hankang Capital based?

Hankang Capital is headquartered in Shanghai, China.

When was Hankang Capital founded?

Hankang Capital was founded in 2010.

How many portfolio companies does Hankang Capital have?

Hankang Capital has 1 portfolio company in Caplight's dataset.

What are some companies in Hankang Capital's portfolio?

Portfolio companies visible on Caplight include Xiamen LP Pharmaceutical Co., Ltd..

What was Hankang Capital's most recent investment shown here?

Hankang Capital's most recent investment in this portfolio sample was in Xiamen LP Pharmaceutical Co., Ltd. in 2015.

What sectors does Hankang Capital focus on?

Hankang Capital focuses on Healthcare & Life Sciences, Frontier & Industrial Tech.

What company stages does Hankang Capital focus on?

Hankang Capital typically invests at the Early stage.

Firmographic Details

HeadquartersShanghai
Year Founded2010

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?